ObsEva (Group)

https://www.obseva.com

ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful biopharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA. ObsEva's founding assets are innovative products at early stages of clinical development addressing preterm labor. *

	Start	2012-01-01 established
	Today	ObsEva S.A. (Nasdaq: OBSV)
	Industry	nolasiban (OBE001)
	Industry 2	reproductive health
	Person	Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono)
	Person 2	Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc)

	Region	Plan-les-Ouates GE
	Country	Switzerland
	Street	12 Chemin des Aulx
	City	1228 Plan-les-Ouates GE
	Tel	+41-22-552-3840
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for ï¿½About Sectionï¿½:

		Record changed: 2018-04-15